PACS Shares Plunge Amid Postponed Results And Federal Investigation - What's Going On? PACS Group shares down after disclosing federal investigative demands and preliminary results with above-industry average occupancy rates.
Mailbag With Motley Fool Co-Founder Tom Gardner Today's show is a cut of our members-only podcast, "Stock Advisor Roundtable."
7 Growth Stocks to Buy on Corrections for 3X Returns by 2026 These are the growth stocks to buy on corrections as they represent fundamentally strong companies with impending growth catalysts.
Tech Stocks Soar, Treasury Yields Fall On Cool Inflation Data; Starbucks Rockets, Chipotle Plummets: What's Driving Markets Tuesday? A wave of bullish sentiment swept through Wall Street on Tuesday after lower-than-expected producer inflation data solidified expectations for Federal Reserve rate cuts, prompting speculators to increase bets on a more significant 50
PACS Stock Earnings: PACS Group Beats EPS, Beats Revenue for Q2 2024 PACS stock results show that PACS Group beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns These under-the-radar healthcare stocks are on a high growth trajectory and represent companies that recently went public.
7 New Growth Stock Listings That Can Be Long-Term Wealth Creators These are the new growth stocks to buy as they represent under-the-radar companies with sustained growth potential
3 Under-the-Radar IPO Stocks to Buy Before They Double These are the under-the-radar IPO stocks to buy as they represent growth companies with an attractive business outlook.
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
3 New IPOs to Buy for 20-Bagger Returns by 2030 Hot, high-growth IPO stocks to buy represent promising early-stage companies with visibility for multi-fold growth in revenue.
